Kazemi Nazanin Yeganeh, Jain Christopher, Bois Melanie C, Behfar Atta, Olivier Kenneth, Markovic Svetomir N
Medical Scientist Training Program, Mayo Clinic, Rochester, MN.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Mayo Clin Proc Innov Qual Outcomes. 2019 Nov 22;3(4):510-516. doi: 10.1016/j.mayocpiqo.2019.09.005. eCollection 2019 Dec.
Merkel cell carcinoma (MCC) is a rare, rapidly proliferating skin cancer that commonly metastasizes to regional lymph nodes. We present the case of a 73-year-old woman with a history of MCC and non-Hodgkin B-cell lymphoma who presented with second-degree heart block (Mobitz type II) caused by an interatrial mass. Temporary pacing was required before biopsy, which revealed metastatic MCC. Treatment included permanent pacing, anti-programmed cell death ligand 1 immunotherapy, and radiation to the heart resulting in notable decrease in tumor size and normalized cardiac rhythm.
默克尔细胞癌(MCC)是一种罕见的、迅速增殖的皮肤癌,通常会转移至区域淋巴结。我们报告了一例73岁女性病例,该患者有MCC和非霍奇金B细胞淋巴瘤病史,因心房肿物导致二度房室传导阻滞(莫氏Ⅱ型)。活检前需要临时起搏,活检结果显示为转移性MCC。治疗包括永久起搏、抗程序性细胞死亡配体1免疫疗法以及心脏放疗,结果肿瘤大小显著减小,心律恢复正常。